EKB Journal Management System
Volume & Issue: Volume 4, Issue 1, January 2016  XML

1

Biosimilars Revolution

Page 1-2
M. Salah Abdel Baky

2

When to Start Urate Lowering Therapy?

Page 3-5
Adel AE

3

Psychosocial Aspects of Rheumatic Diseases

Page 7-8
AbdelAzeim Elhefny

4

Urinary Podocalyxin and Lupus Nephritis Disease Activity

Page 15-22
Ashraf Mohamed; Mahmoud Awad; Asmaa Enein; Mona Balata; Alaa Alsalawy; Emad Elmasry

5

Assessment of Neutrophil Lymphocyte Ratio in Systemic Sclerosis Patients in Tanta University Hospital: A Promising Marker in Predicting Disease Severity

Page 33-41
Noha Esheba; Abeer Shahba

6

Interleukin-22 and Tumor Necrosis Factor Receptor Associated Factor 1 (TRAF1) in Patients with Rheumatoid Arthritis and Systemic Lupus Erythematosus: Correlation with Disease Activity

Page 43-47
Eman Rashwan; Mai Moaaz; Nevine Mohannad; Mohamed Rahman; Eman Zaghloul

7

Study of Peptidyl Arginine Deiminases 4 (PAD 4) Antibodies in Rheumatoid Arthritis Patients

Page 49-58
Darwish El-Hallous; Nevine Mohannad; Maher Kamel; El-Sayed Radwan

8

Assessment of Cytotoxicity and Genotoxicity in Patients with Rheumatoid Arthritis and its Relation to Disease Activity and Medications

Page 59-66
Sally Tayel; Manal Tayel; Hanan Mahrous; Eiman Soliman

9

Evaluation of Adherence to Drug Treatment in Patients with Rheumatoid Arthritis

Page 68-80
Abd El-Azeim Alhefny; Maryam Abd El-Rahman; Sameh Abd El-Moteleb; Hossam Sakr; Rasha Hassan

10

Year in Review 2015-2016 Rheumatoid Arthritis 2015 American College of Rheumatology guideline for the treatment of rheumatoid arthritis (December 2015)

Page 81-92

11

Lupus mimickers…!

Page 93-94
Howaida Mansour; Nahla Hussin; Rahma Elziaty; Warda Abdelfattah